Related Experiment Videos
Hypotensive effects of dihydropyridine derivatives
Arzneimittel-Forschung
|January 1, 1985
Summary
Nisoldipine, nitrendipine, and nicardipine effectively lowered blood pressure in spontaneously hypertensive rats. Dihydropyridine derivatives reduced blood pressure without significantly increasing heart rate in hypertensive models.
Area of Science:
- Pharmacology
- Cardiovascular Research
- Hypertension Studies
Background:
- Spontaneously hypertensive rats (SHR) serve as a key model for studying hypertension.
- Dihydropyridine derivatives are a class of calcium channel blockers used to treat hypertension.
- Understanding differential drug responses in hypertensive versus normotensive models is crucial for therapeutic development.
Purpose of the Study:
- To compare the effects of six dihydropyridine derivatives and hydralazine on blood pressure and heart rate.
- To evaluate the efficacy of these agents in spontaneously hypertensive rats (SHR) relative to normotensive rats (NR).
- To determine dose-dependent cardiovascular responses, particularly the threshold for hypotensive versus chronotropic effects.
Main Methods:
- Administration of six dihydropyridine derivatives (nifedipine, nisoldipine, nitrendipine, nicardipine, nimodipine, niludipine) and hydralazine.
- Measurement of blood pressure and heart rate in spontaneously hypertensive rats (SHR) and normotensive rats (NR).
- Comparative analysis of hypotensive and chronotropic effects across different drug doses and rat models.
Main Results:
- Nisoldipine, nitrendipine, and nicardipine demonstrated a more pronounced hypotensive effect in SHR compared to NR.
- All studied dihydropyridine derivatives, notably nifedipine, nitrendipine, and niludipine, lowered SHR blood pressure at lower doses than those causing a positive chronotropic effect.
- Hydralazine produced similar hypotensive effects in both SHR and NR, but induced tachycardia at doses lower than those required for blood pressure reduction.
Conclusions:
- Specific dihydropyridine derivatives exhibit enhanced hypotensive efficacy in the spontaneously hypertensive rat model.
- Certain dihydropyridines offer a therapeutic window where blood pressure reduction occurs without significant heart rate increase.
- Hydralazine's cardiovascular effects are less selective, causing both blood pressure decrease and tachycardia at comparable low doses.